Abstract
Disease spread can be affected by pharmaceutical (such as vaccination) and non-pharmaceutical interventions (such as physical distancing, mask-wearing, and contact tracing). Understanding the relationship between disease dynamics and human behavior is a significant factor to controlling infections. In this work, we propose a compartmental epidemiological model for studying how the infection dynamics of COVID-19 evolves for people with different levels of social distancing, natural immunity, and vaccine-induced immunity. Our model recreates the transmission dynamics of COVID-19 in Ontario up to December 2021. Our results indicate that people change their behaviour based on the disease dynamics and mitigation measures. Specifically, they adapt more protective behaviour when the number of infections is high and social distancing measures are in effect, and they recommence their activities when vaccination coverage is high and relaxation measures are introduced. We demonstrate that waning of infection and vaccine-induced immunity are important for reproducing disease transmission in Fall 2021.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by NSERC (JMH, IM), CIHR (JMH), and the OMNI-REUNI NSERC-PHAC Emerging Infectious Disease Modelling Initiative (JMH, IM). JM would like to acknowledge support from an OMNI-REUNI postdoctoral fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵+ imoyles{at}yorku.ca
Data Availability
All data produced are available online at: https://data.ontario.ca/en/dataset/status-of-covid-19-cases-in-ontario, https://data.ontario.ca/en/dataset/covid-19-vaccine-data-in-ontario, and https://www.covid19immunitytaskforce.ca/seroprevalence-in-canada/.
